RT Journal Article
SR Electronic
T1 A cross ancestry genetic study of psychiatric disorders from India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.25.24306377
DO 10.1101/2024.04.25.24306377
A1 Holla, Bharath
A1 Mahadevan, Jayant
A1 Ganesh, Suhas
A1 Sud, Reeteka
A1 Janardhanan, Meghana
A1 Balachander, Srinivas
A1 Strom, Nora
A1 Mattheisen, Manuel
A1 Sullivan, Patrick F
A1 Huang, Hailiang
A1 Zandi, Peter
A1 Benegal, Vivek
A1 Reddy, YC Janardhan
A1 Jain, Sanjeev
A1 cVEDA collaborators
A1 ADBS-CBM consortium
A1 iPSYCH OCD consortium
A1 Consortium NORDiC OCD & Related Disorders
A1 Purushottam, Meera
A1 Viswanath, Biju
YR 2024
UL http://medrxiv.org/content/early/2024/04/27/2024.04.25.24306377.abstract
AB Genome-wide association studies across diverse populations may help validate and confirm genetic contributions to risk of disease. We estimated the extent of population stratification as well as the predictive accuracy of polygenic scores (PGS) derived from European samples to a data set from India. We analysed 2685 samples from two data sets, a population neurodevelopmental study (cVEDA) and a hospital-based sample of bipolar affective disorder (BD) and obsessive-compulsive disorder (OCD). Genotyping was conducted using Illumina’s Global Screening Array.Population structure was examined with principal component analysis (PCA), uniform manifold approximation and projection (UMAP), support vector machine (SVM) ancestry predictions, and admixture analysis. PGS were calculated from the largest available European discovery GWAS summary statistics for BD, OCD, and externalizing traits using two Bayesian methods that incorporate local linkage disequilibrium structures (PGS-CS-auto) and functional genomic annotations (SBayesRC). Our analyses reveal global and continental PCA overlap with other South Asian populations. Admixture analysis revealed a north-south genetic axis within India (FST 1.6%). The UMAP partially reconstructed the contours of the Indian subcontinent.The Bayesian PGS analyses indicates moderate-to-high predictive power for BD. This was despite the cross-ancestry bias of the discovery GWAS dataset, with the currently available data. However, accuracy for OCD and externalizing traits was much lower. The predictive accuracy was perhaps influenced by the sample size of the discovery GWAS and phenotypic heterogeneity across the syndromes and traits studied. Our study results highlight the accuracy and generalizability of newer PGS models across ancestries. Further research, across diverse populations, would help understand causal mechanisms that contribute to psychiatric syndromes and traits.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDBT/Wellcome Trust India Alliance: Intermediate Clinical Fellowship (IA/CPHI/20/1/505266), Scientific Knowledge for Ageing and Neurological Ailments (SKAN) trust: (SKAN/002/208/2021/014), Indian Council of Medical Research for CVEDA and OCD genetics, ADBS program funded by the Department of Biotechnology and the Pratiksha Trust ((BT/PR17316/MED/31/326/2015), Center for Brain and Mind (CBM) funded by the Rohini Nilekani Philanthropies, NIMH grants, NIMH R01 MH130675-01 (Asian Bipolar Genetics Network), NIMH R01 MH121545 (Genetics at an extreme: an efficient genomic study of individuals with clinically severe major depression receiving ECT).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All subjects provided written informed consent, and the studies were approved by the ethics committee at NIMHANS.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors